| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/03/1998 | US5714344 Protease-derivatized CVF |
| 02/03/1998 | US5714334 Gene and method for production of an IgA binding protein |
| 02/03/1998 | US5714328 RNA photocleavage using texaphyrins |
| 02/03/1998 | US5714325 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood |
| 02/03/1998 | US5714323 Over expression of single-stranded molecules |
| 02/03/1998 | US5714320 Annealing oligonucleotide primer to single-stranded circular template, combining with nucleotide tripolyphosphates and polymerase enzyme to yield single-stranded oligonucleotide multimer, cleaving |
| 02/03/1998 | US5714316 Chimeric envelope proteins for viral targeting |
| 02/03/1998 | US5714314 Hepatitis C virus antigen polypeptide, production method therefor, and antibody detection method |
| 02/03/1998 | US5714313 Simple method for detecting inhibitors of retroviral replication |
| 02/03/1998 | US5714312 Procedure for the detection and identification of viral and subviral pathogens |
| 02/03/1998 | US5714170 Antisense therapy administered by inserting a tumor cell-containing diffusion chamber into a mammal; side effect reduction |
| 02/03/1998 | US5714166 Bioactive and/or targeted dendrimer conjugates |
| 02/03/1998 | US5714153 Administering antibody inducing dose of recombinant herpes simplex virus comprising synthetic herpes simplex virus promoter linked to heterologous gene |
| 02/03/1998 | US5714152 Herpes simplex virus VP16 vaccines |
| 02/03/1998 | US5714147 Binding endothelial cell with a fused lymphocyte homing receptor polypeptide to prevent the binding of a lymphocyte |
| 02/03/1998 | US5714146 Increasing osteoblast activity in mammal exhibiting decreased bone formation by administering interleukin-4 antagonist; osteoporosis treatment |
| 02/03/1998 | US5714145 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 02/03/1998 | CA1339654C Gene therapy using gene fusion for genetic or acquired disorders |
| 02/03/1998 | CA1339653C Appartus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps |
| 02/01/1998 | CA2182421A1 Phosphate starvation-inducible proteins |
| 01/29/1998 | WO1998003873A1 Treatment and diagnosis of cancer |
| 01/29/1998 | WO1998003682A1 Prolactin receptor gene as a genetic marker for increased litter size in pigs |
| 01/29/1998 | WO1998003681A1 PROBES FOR DETECTING AND IDENTIFYING $i(HELICOBACTER PYLORI) |
| 01/29/1998 | WO1998003680A1 Methods for judging the possibility of the onset of bovine leukemia and the resistance thereto |
| 01/29/1998 | WO1998003676A1 Process for detecting effectors of intra- and/or intercellular protein-protein interactions |
| 01/29/1998 | WO1998003674A1 Dna purification procedure |
| 01/29/1998 | WO1998003673A1 High fidelity detection of nucleic acid differences by ligase detection reaction |
| 01/29/1998 | WO1998003670A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 01/29/1998 | WO1998003669A2 Vectors for inhibiting hiv and tumor growth |
| 01/29/1998 | WO1998003668A1 Virus resistance in plants |
| 01/29/1998 | WO1998003667A1 SYSTEMS FOR THE MASS PRODUCTION OF PROTEINS OR PEPTIDES BY MICROORGANISMS OF THE GENUS $i(HUMICOLA) |
| 01/29/1998 | WO1998003666A1 Recombinant vectors |
| 01/29/1998 | WO1998003665A1 Human kallikrein |
| 01/29/1998 | WO1998003664A1 DEFORMYLATION OF f-MET PEPTIDES IN BACTERIAL EXPRESSION SYSTEMS |
| 01/29/1998 | WO1998003663A1 Human taki dna encoding the same |
| 01/29/1998 | WO1998003662A2 Drosophila melanogaster p70 s6 kinase |
| 01/29/1998 | WO1998003660A1 Feline polynucleotide vaccine formula |
| 01/29/1998 | WO1998003659A1 Avian polynucleotide vaccine formula |
| 01/29/1998 | WO1998003658A1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 01/29/1998 | WO1998003657A1 Viral interleukin-6 |
| 01/29/1998 | WO1998003656A1 Recombinant sef14 fimbrial protein from salmonella |
| 01/29/1998 | WO1998003655A2 Gene expression regulatory dna, expression cassette, expression vector and transgenic plant |
| 01/29/1998 | WO1998003654A2 High-affinity interleukin-4 muteins |
| 01/29/1998 | WO1998003653A2 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 01/29/1998 | WO1998003652A2 P300/cbp-associated transcriptional co-factor p/caf and uses thereof |
| 01/29/1998 | WO1998003651A1 Human osteoclast-specific and -related dna sequences |
| 01/29/1998 | WO1998003650A1 Ninjurin |
| 01/29/1998 | WO1998003649A1 Constructs and complexes of cyclin e |
| 01/29/1998 | WO1998003648A1 Fas ligand-like protein, its production and use |
| 01/29/1998 | WO1998003647A2 Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system |
| 01/29/1998 | WO1998003646A1 Compositions and methods for treating specific gene expression-related diseases and disorders in humans |
| 01/29/1998 | WO1998003645A1 Transmembrane trapping methods |
| 01/29/1998 | WO1998003644A1 Transgenic animal model for alzheimer disease |
| 01/29/1998 | WO1998003643A2 Transgenic animals with mutant human app or a4ct sequences |
| 01/29/1998 | WO1998003640A1 Enzyme endoglucanase and cellulase preparations containing the same |
| 01/29/1998 | WO1998003639A1 PROTEIN ENGINEERING OF GLUCOAMYLASE TO INCREASE pH OPTIMUM, SUBSTRATE SPECIFICITY AND THERMOSTABILITY |
| 01/29/1998 | WO1998003637A1 Bacterial sucrose synthase compositions and methods of use |
| 01/29/1998 | WO1998003635A1 Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same |
| 01/29/1998 | WO1998003634A1 Methods for identifying vasoprotective agents |
| 01/29/1998 | WO1998003631A1 Method of increasing growth and yield in plants |
| 01/29/1998 | WO1998003630A1 Baking yeast strain cect10868 and baking strain cect10869; method for the production thereof by means of recombinant dna techniques and their application as baking yeasts |
| 01/29/1998 | WO1998003551A1 Cd6 ligand |
| 01/29/1998 | WO1998003549A1 MELATONIN 1a RECEPTOR GENE REGULATORY REGIONS AND USES THEREOF |
| 01/29/1998 | WO1998003544A1 IDENTIFICATION OF SHORT PEPTIDE SEQUENCES REPRESENTING EPITOPES OF GLYCOPROTEIN G OF HSV-2 USING A PHAGE PEPTIDE DISPLAY LIBRARY FOR USE IN AN ANTI-gG2 ELISA |
| 01/29/1998 | WO1998003543A1 Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library |
| 01/29/1998 | WO1998003542A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 01/29/1998 | WO1998003541A1 Conantokins |
| 01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
| 01/29/1998 | WO1998003538A2 Signal-regulated, cleavage-mediated toxins |
| 01/29/1998 | WO1998003536A1 Chemically-inducible arabidopsis pr-1 promoter |
| 01/29/1998 | WO1998003535A1 Manipulation of lignin composition in plants using a tissue-specific promoter |
| 01/29/1998 | WO1998003533A1 Antisense oligonucleotides as antibacterial agents |
| 01/29/1998 | WO1998003206A1 The butyrophilin gene promoter and uses thereof |
| 01/29/1998 | WO1998003200A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 01/29/1998 | WO1998003199A1 Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases |
| 01/29/1998 | WO1998003198A1 Polynucleotide vaccine formula for treating horse diseases |
| 01/29/1998 | WO1998003196A1 Intradermal bovine polynucleotide vaccine |
| 01/29/1998 | WO1998003195A1 Methods and compositions for modulation of growth response |
| 01/29/1998 | WO1998003060A1 Hepatitis c model animals |
| 01/29/1998 | WO1998003059A1 Galanin |
| 01/29/1998 | WO1997047732A3 Hexameric fusion proteins and uses therefor |
| 01/29/1998 | WO1997044463A3 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 01/29/1998 | WO1997041234A3 PROTEINS INVOLVED IN THE SYNTHESIS AND ASSEMBLY OF O-ANTIGEN IN $i(PSEUDOMONAS AERUGINOSA) |
| 01/29/1998 | DE19732136A1 Gefrorenes Nahrungsmittelprodukt A frozen food product |
| 01/29/1998 | DE19732132A1 Gefrorenes Nahrungsmittelprodukt A frozen food product |
| 01/29/1998 | DE19632755C1 Monoclonal antibody specific for CDw109 cell surface protein |
| 01/29/1998 | DE19630390A1 Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung Proteins, especially membrane proteins from Helicobacter pylori, their preparation and use |
| 01/29/1998 | DE19630230A1 Herstellung immunstimulierender Mittel auf Basis von Propionibakterien Preparation of immunostimulating agents based on propionibacteria |
| 01/29/1998 | CA2588670A1 Vectors for inhibiting hiv and tumor growth |
| 01/29/1998 | CA2261996A1 Methods for judging the possibility of the onset of bovine leukemia and the resistance thereto |
| 01/29/1998 | CA2261568A1 Conantokins |
| 01/29/1998 | CA2261566A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 01/29/1998 | CA2261343A1 Avian polynucleotide vaccine formula |
| 01/29/1998 | CA2261016A1 Deformylation of f-met peptides in bacterial expression systems |
| 01/29/1998 | CA2261013A1 Human kallikrein |
| 01/29/1998 | CA2260907A1 Manipulation of lignin composition in plants using a tissue-specific promoter |
| 01/29/1998 | CA2260767A1 Fas ligand-like protein, its production and use |
| 01/29/1998 | CA2260763A1 Melatonin 1a receptor gene regulatory regions and uses thereof |
| 01/29/1998 | CA2260752A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 01/29/1998 | CA2260748A1 Human osteoclast-specific and -related dna sequences |